4722 related articles for article (PubMed ID: 6143562)
41. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
Harrison SD; O'Dwyer PJ; Trader MW
Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
[TBL] [Abstract][Full Text] [Related]
42. Sequential impact of tiazofurin and ribavirin on the enzymic program of the bone marrow.
Prajda N; Hata Y; Abonyi M; Singhal RL; Weber G
Cancer Res; 1993 Dec; 53(24):5982-6. PubMed ID: 7903199
[TBL] [Abstract][Full Text] [Related]
43. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
Sokoloski JA; Sartorelli AC
Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
[TBL] [Abstract][Full Text] [Related]
44. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of thiazole-4-carboxamide adenine dinucleotide. A powerful inhibitor of IMP dehydrogenase.
Gebeyehu G; Marquez VE; Kelley JA; Cooney DA; Jayaram HN; Johns DG
J Med Chem; 1983 Jun; 26(6):922-5. PubMed ID: 6133956
[TBL] [Abstract][Full Text] [Related]
46. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
Fridland A; Connelly MC; Robbins TJ
Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
[TBL] [Abstract][Full Text] [Related]
47. The disposition and metabolism of tiazofurin in rodents, rabbits, and dogs.
Arnold ST; Jayaram HN; Harper GR; Litterst CL; Malspeis L; DeSouza JJ; Staubus AE; Ahluwalia GS; Wilson YA; Cooney DA
Drug Metab Dispos; 1984; 12(2):165-73. PubMed ID: 6144481
[TBL] [Abstract][Full Text] [Related]
48. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.
Franchetti P; Grifantini M
Curr Med Chem; 1999 Jul; 6(7):599-614. PubMed ID: 10390603
[TBL] [Abstract][Full Text] [Related]
49. Critical issues in chemotherapy with tiazofurin.
Weber G
Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
[TBL] [Abstract][Full Text] [Related]
50. Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.
Tricot GJ; Jayaram HN; Nichols CR; Pennington K; Lapis E; Weber G; Hoffman R
Cancer Res; 1987 Sep; 47(18):4988-91. PubMed ID: 3476200
[TBL] [Abstract][Full Text] [Related]
51. p210 bcr-abl confers overexpression of inosine monophosphate dehydrogenase: an intrinsic pathway to drug resistance mediated by oncogene.
Gharehbaghi K; Burgess GS; Collart FR; Litz-Jackson S; Huberman E; Jayaram HN; Boswell HS
Leukemia; 1994 Aug; 8(8):1257-63. PubMed ID: 7520100
[TBL] [Abstract][Full Text] [Related]
52. Crystallographic studies of two alcohol dehydrogenase-bound analogues of thiazole-4-carboxamide adenine dinucleotide (TAD), the active anabolite of the antitumor agent tiazofurin.
Li H; Hallows WH; Punzi JS; Marquez VE; Carrell HL; Pankiewicz KW; Watanabe KA; Goldstein BM
Biochemistry; 1994 Jan; 33(1):23-32. PubMed ID: 8286346
[TBL] [Abstract][Full Text] [Related]
53. Nicotinamide mononucleotide adenylyltransferase2 overexpression enhances colorectal cancer cell-kill by Tiazofurin.
Kusumanchi P; Zhang Y; Jani MB; Jayaram NH; Khan RA; Tang Y; Antony AC; Jayaram HN
Cancer Gene Ther; 2013 Jul; 20(7):403-12. PubMed ID: 23764899
[TBL] [Abstract][Full Text] [Related]
54. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
[TBL] [Abstract][Full Text] [Related]
55. Involvement of guanine nucleotides in superoxide release by fluoride-treated neutrophils. Implications for a role of a guanine nucleotide regulatory protein.
English D; Rizzo MT; Tricot G; Hoffman R
J Immunol; 1989 Sep; 143(5):1685-91. PubMed ID: 2547872
[TBL] [Abstract][Full Text] [Related]
56. The chemistry of nicotinamide adenine dinucleotide (NAD) analogues containing C-nucleosides related to nicotinamide riboside.
Pankiewicz KW; Watanabe KA; Lesiak-Watanabe K; Goldstein BM; Jayaram HN
Curr Med Chem; 2002 Apr; 9(7):733-41. PubMed ID: 11966436
[TBL] [Abstract][Full Text] [Related]
57. Synergistic action of tiazofurin and genistein on growth inhibition and differentiation of K-562 human leukemic cells.
Li W; Weber G
Life Sci; 1998; 63(22):1975-81. PubMed ID: 9839541
[TBL] [Abstract][Full Text] [Related]
58. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
Saunders PP; Kuttan R; Lai MM; Robins RK
Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
[TBL] [Abstract][Full Text] [Related]
59. The conversion of 2-beta-D-ribofuranosylthiazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.
Cooney DA; Jayaram HN; Gebeyehu G; Betts CR; Kelley JA; Marquez VE; Johns DG
Biochem Pharmacol; 1982 Jun; 31(11):2133-6. PubMed ID: 6126195
[No Abstract] [Full Text] [Related]
60. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-beta-D-ribofuranosylthiazole-4-carboxamide (NSC 286193).
Jayaram HN; Dion RL; Glazer RI; Johns DG; Robins RK; Srivastava PC; Cooney DA
Biochem Pharmacol; 1982 Jul; 31(14):2371-80. PubMed ID: 6127085
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
